High expression of SMPD4 promotes liver cancer and is associated with poor prognosis
Abstract Objectives The expression of sphingomyelin phosphodiesterase 4 (SMPD4), a neutral sphingomyelin enzyme, is intricately associated with tumorigenesis and progression. However, its role in hepatocellular carcinoma (HCC) remains unclear. This study mainly reports the expression, prognostic val...
Saved in:
| Main Authors: | Rongyue Wang, Ting Wang, Yanze Su, Zhiheng Lin, Xiaoping Liu, Yuanjun Jiao, Jikui Liu, Erbao Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Research Notes |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13104-025-07212-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenging the conventional wisdom: Re‐evaluating Smpd3's role in extracellular vesicle biogenesis
by: Marlies Burgelman, et al.
Published: (2024-11-01) -
Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
by: Zhongchao Zhang, et al.
Published: (2025-03-01) -
The Ceramide-Dependent EV Secretome Differentially Affects Prostate Cancer Cell Migration
by: Dolma Choezom, et al.
Published: (2025-04-01) -
Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma
by: Chang-Qing Yin, et al.
Published: (2024-12-01) -
Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma
by: Tianchen Zhang, et al.
Published: (2023-02-01)